Closing the Testing Gap: An Analytical and Microbiological Framework for FDA-Compliant 503A and 503B Compounding Pharmacies
American Journal of Analytical Chemistry · 2026 · 17 (06) · 212-234
DOI: 10.4236/ajac.2026.176013 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Analytical Chemistry, 2026. Verfasst von Mem Rani und 5 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Rani, M., Patel, N., Duppala, M., Ragusa, A., Darji, M., & Hotha, K. K. (2026). Closing the Testing Gap: An Analytical and Microbiological Framework for FDA-Compliant 503A and 503B Compounding Pharmacies. American Journal of Analytical Chemistry, 17(06), 212-234. https://doi.org/10.4236/ajac.2026.176013
Vancouver
Rani M, Patel N, Duppala M, Ragusa A, Darji M, Hotha KK. Closing the Testing Gap: An Analytical and Microbiological Framework for FDA-Compliant 503A and 503B Compounding Pharmacies. American Journal of Analytical Chemistry. 2026;17(06):212-234. doi:10.4236/ajac.2026.176013
BibTeX
@article{Rani2026,
author = {Rani, Mem and Patel, Nansiben and Duppala, Mounika and Ragusa, Alyssa and Darji, Megha and Hotha, Kishore Kumar},
title = {Closing the Testing Gap: An Analytical and Microbiological Framework for FDA-Compliant 503A and 503B Compounding Pharmacies},
journal = {American Journal of Analytical Chemistry},
year = {2026},
volume = {17},
number = {06},
pages = {212--234},
doi = {10.4236/ajac.2026.176013}
}
EUVIMED